Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease
Authors Raed Osman, Philippe L L’Allier, Nader Elgharib, Jean-Claude Tardif
Published 15 September 2006 Volume 2006:2(3) Pages 221—237
Raed Osman1, Philippe L L’Allier1, Nader Elgharib, Jean-Claude Tardif
Department of Medicine, Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada. 1These authors contributed equally to this work.
Abstract: Clinicians involved in the care of patients with cardiovascular conditions have recently been confronted with an important body of literature linking inflammation and cardiovascular disease. Indeed, the level of systemic inflammation as measured by circulating levels of C-reactive protein (CRP) has been linked to prognosis in patients with atherosclerotic disease, congestive heart failure, atrial fibrillation, myocarditis, aortic valve disease and heart transplantation. In addition, a number of basic science reports suggest an active role for CRP in the athophysiology of cardiovascular diseases. This article explores the potential role of CRP in disease initiation, progression, and clinical manifestations and reviews its role in the prediction of future events in clinical practice. Therapeutic interventions to decrease circulating levels of CRP are also reviewed.
Keywords: C-reactive protein, inflammation, atherosclerosis, risk prediction, cardiovascular disease, acute coronary syndrome